Clinical efficacy and safety profile of palbociclib (P) in combination with letrozole (L) as first-line treatment in patients (pts) with ER+ and HER2- advanced breast cancer (ABC) who have not received any systemic treatment (ST): A subgroup analysis of PALOMA-1/TRIO-18.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 575-575
Author(s):  
Richard S. Finn ◽  
John Crown ◽  
Johannes Ettl ◽  
Tamas Pinter ◽  
Anu Thummala ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Clinical Efficacy ◽  
Subgroup Analysis ◽  
Safety Profile ◽  
Systemic Treatment ◽  
Line Treatment ◽  
Efficacy And Safety ◽  
First Line ◽  
First Line Treatment

scholarly journals Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer

Medicine ◽  
2017 ◽  
Vol 96 (33) ◽  
pp. e7846 ◽  
Author(s):  
Jingwen Zhang ◽  
Yanhong Huang ◽  
Changyi Wang ◽  
Yuanfang He ◽  
Shukai Zheng ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Line Treatment ◽  
Efficacy And Safety ◽  
First Line ◽  
Hormone Sensitive ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document